Longitudinal model-based meta-analysis for survival probabilities in patients with castration-resistant prostate cancer.

Wenjun ChenLiang LiShuangmin JiXuyang SongWei LuTianyan Zhou

Published in: European journal of clinical pharmacology (2020)

Our modeling and simulation framework can be applied to support indirect comparison, dose selection, and go/no-go decision-making for new agents targeting CRPC.

Keyphrases

decision making
systematic review
meta analyses
cancer therapy
cross sectional
case control